|
1
|
Krasnokutsky S, Samuels J and Abramson SB:
Osteoarthritis in 2007. Bull NYU Hosp Jt Dis. 65:222–228. 2007.
|
|
2
|
Kapoor M, Martel-Pelletier J, Lajeunesse
D, Pelletier JP and Fahmi H: Role of proinflammatory cytokines in
the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 71:33–42.
2011. View Article : Google Scholar
|
|
3
|
Goldring MB and Goldring SR:
Osteoarthritis. J Cell Physiol. 213:626–634. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yusuf E: Metabolic factors in
osteoarthritis: obese people do not walk on their hands. Arthritis
Res Ther. 14:1232012. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cicuttini FM, Baker JR and Spector TD: The
association of obesity with osteoarthritis of the hand and knee in
women: a twin study. J Rheumatol. 23:1221–1226. 1996.PubMed/NCBI
|
|
6
|
Yusuf E: Metabolic factors in
osteoarthritis: obese people do not walk on their hands. Arthritis
Res Ther. 14:1232012. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bay-Jensen AC, Slagboom E, Chen-An P, et
al: Role of hormones in cartilage and joint metabolism:
understanding an unhealthy metabolic phenotype in osteoarthritis.
Menopause. 20:578–586. 2013.PubMed/NCBI
|
|
8
|
Hida K, Wada J, Eguchi J, et al: Visceral
adipose tissue-derived serine protease inhibitor: a unique
insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci
USA. 102:10610–10615. 2005. View Article : Google Scholar
|
|
9
|
Fain JN, Buehrer B, Bahouth SW, Tichansky
DS and Madan AK: Comparison of messenger RNA distribution for 60
proteins in fat cells vs the nonfat cells of human omental adipose
tissue. Metabolism. 57:1005–1015. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Klöting N, Berndt J, Kralisch S, et al:
Vaspin gene expression in human adipose tissue: association with
obesity and type 2 diabetes. Biochem Biophys Res Commun.
339:430–436. 2006.
|
|
11
|
Meyer-Hoffert U: Reddish, scaly, and
itchy: how proteases and their inhibitors contribute to
inflammatory skin diseases. Arch Immunol Ther Exp (Warsz).
57:345–354. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Klöting N, Kovacs P, Kern M, et al:
Central vaspin administration acutely reduces food intake and has
sustained blood glucose-lowering effects. Diabetologia.
54:1819–1823. 2011.
|
|
13
|
Körner A, Neef M, Friebe D, et al: Vaspin
is related to gender, puberty and deteriorating insulin sensitivity
in children. Int J Obes (Lond). 35:578–586. 2011.PubMed/NCBI
|
|
14
|
Youn BS, Klöting N, Kratzsch J, et al:
Serum vaspin concentrations in human obesity and type 2 diabetes.
Diabetes. 57:372–377. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ozgen M, Koca SS, Dagli N, Balin M,
Ustundag B and Isik A: Serum adiponectin and vaspin levels in
rheumatoid arthritis. Arch Med Res. 41:457–463. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Klaasen R, Herenius MM, Wijbrandts CA, et
al: Treatment-specific changes in circulating adipocytokines: a
comparison between tumour necrosis factor blockade and
glucocorticoid treatment for rheumatoid arthritis. Ann Rheum Dis.
71:1510–1516. 2012. View Article : Google Scholar
|
|
17
|
Senolt L, Polanská M, Filková M, et al:
Vaspin and omentin: new adipokines differentially regulated at the
site of inflammation in rheumatoid arthritis. Ann Rheum Dis.
69:1410–1411. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kamio N, Kawato T, Tanabe N, et al: Vaspin
attenuates RANKL-induced osteoclast formation in RAW264.7 cells.
Connect Tissue Res. 54:147–152. 2013. View Article : Google Scholar
|
|
19
|
Choi SH, Hong ES and Lim S: Clinical
implications of adipocytokines and newly emerging metabolic factors
with relation to insulin resistance and cardiovascular health.
Front Endocrinol (Lausanne). 4:972013.PubMed/NCBI
|
|
20
|
Wada J: Vaspin: a novel serpin with
insulin-sensitizing effects. Expert Opin Investig Drugs.
17:327–333. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kadoglou NP, Gkontopoulos A, Kapelouzou A,
et al: Serum levels of vaspin and visfatin in patients with
coronary artery disease-Kozani study. Clin Chim Acta. 412:48–52.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Phalitakul S, Okada M, Hara Y and Yamawaki
H: Vaspin prevents methylglyoxal-induced apoptosis in human
vascular endothelial cells by inhibiting reactive oxygen species
generation. Acta Physiol (Oxf). 209:212–219. 2013.
|
|
23
|
Phalitakul S, Okada M, Hara Y and Yamawaki
H: Vaspin prevents TNF-α-induced intracellular adhesion molecule-1
via inhibiting reactive oxygen species-dependent NF-κB and PKCθ
activation in cultured rat vascular smooth muscle cells. Pharmacol
Res. 64:493–500. 2011.PubMed/NCBI
|
|
24
|
Kukla M, Mazur W, Bułdak RJ and
Zwirska-Korczala K: Potential role of leptin, adiponectin and three
novel adipokines - visfatin, chemerin and vaspin - in chronic
hepatitis. Mol Med. 17:1397–1410. 2011. View Article : Google Scholar
|
|
25
|
Fu BD, Yamawaki H, Okada M and Hara Y:
Vaspin can not inhibit TNF-α-induced inflammation of human
umbilical vein endothelial cells. J Vet Med Sci. 71:1201–1207.
2009.
|
|
26
|
Bao JP, Chen WP, Feng J, Hu PF, Shi ZL and
Wu LD: Leptin plays a catabolic role on articular cartilage. Mol
Biol Rep. 37:3265–3272. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu PF, Chen WP, Tang JL, Bao JP and Wu LD:
Apelin plays a catabolic role on articular cartilage: in vivo and
in vitro studies. Int J Mol Med. 26:357–363. 2010.PubMed/NCBI
|
|
28
|
Uchida K, Urabe K, Naruse K, Ogawa Z,
Mabuchi K and Itoman M: Hyperlipidemia and hyperinsulinemia in the
spontaneous osteoarthritis mouse model, STR/Ort. Exp Anim.
58:181–187. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen TH, Chen L, Hsieh MS, Chang CP, Chou
DT and Tsai SH: Evidence for a protective role for adiponectin in
osteoarthritis. Biochim Biophys Acta. 1762:711–718. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hsieh YS, Yang SF, Chu SC, et al:
Expression changes of gelatinases in human osteoarthritic knees and
arthroscopic debridement. Arthroscopy. 20:482–488. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Birkedal-Hansen H, Moore WG, Bodden MK, et
al: Matrix metalloproteinases: a review. Crit Rev Oral Biol Med.
4:197–250. 1993.PubMed/NCBI
|
|
32
|
Kozaci LD, Buttle DJ and Hollander AP:
Degradation of type II collagen, but not proteoglycan, correlates
with matrix metalloproteinase activity in cartilage explant
cultures. Arthritis Rheum. 40:164–174. 1997. View Article : Google Scholar
|
|
33
|
Fushimi K, Troeberg L, Nakamura H, Lim NH
and Nagase H: Functional differences of the catalytic and
non-catalytic domains in human ADAMTS-4 and ADAMTS-5 in
aggrecanolytic activity. J Biol Chem. 283:6706–6716. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Handley CJ, Mok MT, Ilic MZ, Adcocks C,
Buttle DJ and Robinson HC: Cathepsin D cleaves aggrecan at unique
sites within the interglobular domain and chondroitin sulfate
attachment regions that are also cleaved when cartilage is
maintained at acid pH. Matrix Biol. 20:543–553. 2001. View Article : Google Scholar
|
|
35
|
Chabane N, Zayed N, Afif H, et al: Histone
deacetylase inhibitors suppress interleukin-1β-induced nitric oxide
and prostaglandin E2 production in human chondrocytes.
Osteoarthritis Cartilage. 16:1267–1274. 2008.
|
|
36
|
Salvemini D, Misko TP, Masferrer JL,
Seibert K, Currie MG and Needleman P: Nitric oxide activates
cyclooxygenase enzymes. Proc Natl Acad Sci USA. 90:7240–7244. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sasaki K, Hattori T, Fujisawa T, Takahashi
K, Inoue H and Takigawa M: Nitric xide mediates
interleukin-1-induced gene expression of matrix metalloproteinases
and basic fibroblast growth factor in cultured rabbit articular
chondrocytes. J Biochem. 123:431–439. 1998. View Article : Google Scholar
|
|
38
|
Amin AR, Attur M, Patel RN, et al:
Superinduction of cyclooxygenase-2 activity in human
osteoarthritis-affected cartilage. Influence of nitric oxide. J
Clin Invest. 99:1231–1237. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang P, Zhu F and Konstantopoulos K:
Prostaglandin E2 induces interleukin-6 expression in human
chondrocytes via cAMP/protein kinase A- and phosphatidylinositol
3-kinase-dependent NF-κB activation. Am J Physiol Cell Physio.
298:C1445–C1456. 2010.PubMed/NCBI
|
|
40
|
Vincenti MP and Brinckerhoff CE:
Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in
arthritis: integration of complex signaling pathways for the
recruitment of gene-specific transcription factors. Arthritis Res.
4:157–164. 2002. View
Article : Google Scholar
|
|
41
|
Tian B and Brasier AR: Identification of a
nuclear factor κB-dependent gene network. Recent Prog Horm Res.
58:95–130. 2003.
|
|
42
|
Hayden MS and Ghosh S: Signaling to NF-κB.
Genes Dev. 18:2195–2224. 2004.
|
|
43
|
Li H, Peng W, Zhuang J, et al: Vaspin
attenuates high glucose-induced vascular smooth muscle cells
proliferation and chemokinesis by inhibiting the MAPK, PI3K/Akt,
and NF-κB signaling pathways. Atherosclerosis. 228:61–68.
2013.PubMed/NCBI
|
